A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

ClinicalTrials.gov ID: NCT01502020

Public ClinicalTrials.gov record NCT01502020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Study identification

NCT ID: NCT01502020
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Actavis Mid-Atlantic LLC; Industry
Enrollment: 410 participants

Conditions and interventions

Conditions

Actinic Keratoses

Interventions

imiquimod cream, 3.75% Drug
Vehicle Cream Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2011
Primary completion: Jul 31, 2011
Completion: Oct 31, 2011
Last update posted: Dec 29, 2011

2011

United States locations

U.S. sites: 19
U.S. states: 16
U.S. cities: 19

Facility	City	State	ZIP	Site status
Total Skin and Beauty Dermatology Center, PC	Birmingham	Alabama	35205	—
International Dermatology Research, Inc.	Miami	Florida	33144	—
MedaPhase, Inc.	Newnan	Georgia	30263	—
Northwest Clinical Trials	Boise	Idaho	83704	—
Altman Dermatology Associates	Arlington Heights	Illinois	60005	—
Deaconess Clinic, Inc.	Evansville	Indiana	47713	—
Indiana Clinical Trials Center	Plainfield	Indiana	46168	—
Dermatology Specialists	Louisville	Kentucky	40202	—
Michigan Center for Research Corp.	Clinton Township	Michigan	48038	—
Minnesota Clinical Study Center	Fridley	Minnesota	55432	—
Skin Specialists, P.C.	Omaha	Nebraska	68144	—
Academic Dermatology Associates	Albuquerque	New Mexico	87106	—
Dermatology, Laser & Vein Specialists of the Carolinas,	Charlotte	North Carolina	28207	—
Dermatology Research Center of Cincinnati	Cincinnati	Ohio	45220	—
Oregon Medical Research Center, PC	Portland	Oregon	97223	—
Philadelphia Institute of Dermatology	Fort Washington	Pennsylvania	19034	—
DermResearch, Inc.	Austin	Texas	78759	—
Suzanne Bruce and Associates, P.A.	Houston	Texas	77056	—
Dermatology Clinical Research Center of San Antonio	San Antonio	Texas	78229	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01502020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 29, 2011 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01502020 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →